Environmental impact assessment of COVID-19 therapeutic solutions. A prospective analysis.

ABSTRACT: Several medicinal products for human use are currently under consideration as potential treatment for COVID-19 pandemic. As proposals cover also prophylactic use, the treatment could be massive, resulting in unprecedent levels of antiviral emissions to the aquatic environment. We have adapted previous models and used available information for predicting the environmental impact of representative medicinal products, covering the main groups under consideration: multitarget antiparasitic (chloroquines and ivermectin), glucocorticoids, macrolide antibiotics and antiviral drugs including their pharmacokinetic boosters. The retrieved information has been sufficient for conducting a conventional environmental risk assessment for the group of miscellaneous medicines; results suggest low concern f

SUBMITTER: Tarazona JV 

PROVIDER: S-EPMC7943388 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature